News search

María Ángeles Moro leads the CNIC's Neurovascular Pathophysiology Laboratory.

The study, published in Europace, uses signals from implantable devices—pacemakers and defibrillators—to analyze electrical signals in the heart during episodes of atrial fibrillation

Dr. Miguel Torres, of the Centro Nacional de Investigaciones Cardiovasculares (CNIC), leads a new project that will receive €8 million in funding over 5 years, €1,380,000 of which will be directly managed at the CNIC

One of the diseases most affected by aging is cardiovascular illness. In fact, it is already considered the most important risk factor for this disease

The project aims to study how certain mutations acquired in blood cells and traditionally associated with a high risk of developing leukemia can also contribute to the development of cardiovascular disease and become a new and independent cardiovascular risk factor to classical factors

Scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) and Puerta de Hierro hospital in Majadahonda have found a possible treatment for this disease

Dr. Valentín Fuster will be teaching the summer seminar series “Molecular, Clinical & Population Bases of Cardiovascular Disease and Health”, organized by the  International University Menéndez Pelayo (UIMP) and the Icahn School of Medicine at Mount Sinai.

The results, published in JACC, demonstrate the potential of this technology to generate images of the inflammation associated with systemic atherosclerosis; this information will be useful for the study of early stages of this disease and will help to identify individuals who will benefit from early medical intervention